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Pariacoto virus (PaV) is a nodavirus that was recently isolated in Peru from the Southern armyworm,
Spodoptera eridania. Virus particles are non enveloped and about 30 nm in diameter and have T3 icosahedral
symmetry. The 3.0-Å crystal structure shows that about 35% of the genomic RNA is icosahedrally ordered, with
the RNA forming a dodecahedral cage of 25-nucleotide (nt) duplexes that underlie the inner surface of the
capsid. The PaV genome comprises two single-stranded, positive-sense RNAs: RNA1 (3,011 nt), which encodes
the 108-kDa catalytic subunit of the RNA-dependent RNA polymerase, and RNA2 (1,311 nt), which encodes the
43-kDa capsid protein precursor . In order to apply molecular genetics to the structure and assembly of PaV,
we identified susceptible cell lines and developed a reverse genetic system for this virus. Cell lines that were
susceptible to infection by PaV included those from Spodoptera exigua, Helicoverpa zea and Aedes albopictus,
whereas cells from Drosophila melanogaster and Spodoptera frugiperda were refractory to infection. To recover
virus from molecular clones, full-length cDNAs of PaV RNAs 1 and 2 were cotranscribed by T7 RNA poly-
merase in baby hamster kidney cells that expressed T7 RNA polymerase. Lysates of these cells were infectious
both for cultured cells from Helicoverpa zea (corn earworm) and for larvae of Galleria mellonella (greater wax
moth). The combination of infectious cDNA clones, cell culture infectivity, and the ability to produce milligram
amounts of virus allows the application of DNA-based genetic methods to the study of PaV structure and
assembly.
Members of the Nodaviridae family are small positive-sense
RNA viruses with T3 icosahedral symmetry (for a review, see
references 4, 5, and 37). Each 30-nm particle is assembled from
180 copies of the capsid protein precursor  and one copy of
each of the two unique segments of the viral RNA genome (24,
30, 41). Viruses from the alphanodavirus genus infect primarily
insects. In alphanodaviruses, the 44-kDa capsid protein pre-
cursor  is autocatalytically cleaved following virion assembly
to yield the two mature capsid proteins  (40 kDa) and  (4
kDa) (20). The maturation cleavage is required for infectivity
(38). The larger genome segment (RNA1) contains 3.0 to 3.2
kb and encodes protein A, the catalytic subunit of the RNA-
dependent RNA polymerase (26). The smaller genome seg-
ment (RNA2) contains 1.3 to 1.4 kb and encodes the capsid
protein precursor, . Both genomic RNAs are capped but not
polyadenylated (9, 10, 22, 28). During replication, a sub-
genomic RNA (RNA3) which is 3 coterminal with RNA1 is
transcribed. RNA3 contains about 400 nucleotides (nt) and
encodes one or two small proteins (B1 and B2) of unknown
function (5, 16, 22).
The best studied alphanodavirus is Flock House virus (FHV),
and reverse genetic systems that allow the infectious cycle of
this virus to be reconstructed from cDNA clones have been
developed. FHV replication can be initiated and infectious
virus can be recovered from in vitro transcripts of RNA1 and
RNA2 transfected into Drosophila melanogaster cells (11) or
from specialized cDNA transcription plasmids transfected into
mammalian cells (2). These approaches have advanced our
understanding of both RNA replication and capsid assembly of
this model virus (5, 6, 25, 37). For example, two regions in the
FHV capsid protein precursor that are involved in RNA en-
capsidation have been identified: (i) protein  that lacks amino
acid residues 1 to 31 assembles into virus-like particles (VLPs)
that encapsidate RNA1 but fail to encapsidate RNA2 (13); (ii)
deleting the C-terminal 26 amino acids (aa) results in the
assembly of VLPs that encapsidate cellular RNAs in place of
the viral genome segments (36). However, most of the capsid
protein regions involved in the specificity of FHV RNA en-
capsidation are not visible in the crystal structure (8, 14).
The structure of the alphanodavirus Pariacoto virus (PaV)
was recently determined, and it significantly extended our un-
derstanding of RNA-protein interactions in nodavirus virions
(43). PaV was isolated in Peru in 1996 from moribund larvae of
the Southern armyworm, Spodoptera eridania (45), and is the
most recent member of the alphanodavirus genus to be char-
acterized. PaV is the most distantly related of the insect no-
daviruses, with its RNA-dependent RNA polymerase and cap-
sid protein sharing less than 29 and 41% sequence identity,
respectively, with those of the other alphanodaviruses (26, 27).
The three-dimensional structure of PaV is generally similar
to that of the other nodaviruses, but with several novel features
(43). First, along each twofold axis of the capsid lies a 25-nt
A-form RNA duplex that is visible at high resolution in the
crystal structure and accounts for 1,500 nt, or approximately
35% of the single-stranded genomic RNA. Thirty such RNA
duplexes are arranged as a dodecahedral cage, with discontin-
uous vertices where the RNA is less ordered and presumably
loops into the interior of the virion. Second, for the first time
in any nodavirus structure, the basic N terminus of one of the
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three quasiequivalent capsid protein monomers in the asym-
metric unit is clearly visible from aa 7 to 51, making numerous
contacts with the RNA duplex. Third, the C-terminal 8 aa of
the same subunit are also visible for the first time, lying in a
protein channel at the quasi-threefold axis. Thus, regions of
the capsid protein that likely influence the specificity of RNA
encapsidation and particle assembly are uniquely visible in the
PaV structure, making it an attractive system for analysis by
molecular genetics.
Such studies require a method by which infectious PaV par-
ticles and VLPs could be recovered from cDNA clones in
quantities large enough for structural analysis. In our previous
work we showed that transfection of PaV virion RNAs into
BHK-21 cells resulted in RNA replication and the synthesis of
both protein A and the capsid protein precursor . To develop
a reverse genetic system, cDNA transcription plasmids encod-
ing PaV RNA1 and RNA2 were transfected into BHK-21 cells
infected with a recombinant vaccinia virus that expressed T7
RNA polymerase to drive primary transcription (27). The
cDNA clones initiated RNA replication and viral protein syn-
thesis, but since BHK-21 cells are not susceptible to infection
with PaV no evidence of infectivity was obtained. In the
present study, we surveyed several insect cell lines for their
susceptibility to infection with PaV and then used the infec-
tious cell culture system to validate the recovery of clonally
derived virus.
MATERIALS AND METHODS
Cells and virus. Except where indicated, all insect cell lines were maintained
at 28°C in medium supplemented with 10% heat-inactivated fetal bovine serum
and antibiotics. Drosophila line 1 and line 2 (DL-1 and DL-2) (39) cells were
maintained in Schneider’s medium (Gibco/BRL), and Spodoptera frugiperda
(Sf9) cells (44) were maintained in Grace’s medium (Gibco/BRL). Cell lines
derived from Aedes aegypti whole larvae (Ae-59) (34), Aedes albopictus whole
larvae (ATC-15) (42), Spodoptera exigua larvae (Se-1) (21), and Helicoverpa zea
fat body cell lines (BCIRL-HZ-FB27 and BCIRL-HZ-FB33, referred to here as
FB27 and FB33, respectively) and a midgut cell line (BCIRL-HZ-MG8, referred
to here as MG8) (29; A. H. McIntosh, personal communication) were main-
tained in ExCell-401 medium (JRH Biologicals) with 10% heat-inactivated fetal
bovine serum, except for the MG8 line, which was maintained in serum-free
medium.
Baby kidney hamster-derived cell line BSR-T7/5 cells (7) were grown at 37°C
as monolayer cultures in modified Eagle’s medium (Gibco/BRL catalogue num-
ber 41200-015) supplemented with 5% fetal calf serum and 5% newborn calf
serum in an atmosphere containing 5% CO2. BSR-T7/5 cells were subcultured in
the continuous presence of the antibiotics penicillin and streptomycin, and in
alternate passages G418 was added to 1 mg/ml to ensure maintenance of the T7
polymerase gene. Wild-type PaV was purified as described previously (27) from
Galleria mellonella larvae inoculated with the original field material collected in
1996 (45).
cDNA clones. The PaV cDNA clones PaV1(0,0) and PaV2(0,0) were described
previously (27). Briefly, reverse transcription (RT)-PCR copies of the two PaV
genome segments were ligated into the transcription vector TVT7R(0,0) be-
tween the T7 promoter and cDNA sequences that encode the hepatitis delta
virus antigenomic ribozyme, followed by the T7 terminator. Following autocat-
alytic cleavage by the hepatitis delta virus ribozyme, the resulting T7 transcripts
had precise 5 and 3 termini with no additional nucleotides at either end, hence
the designation (0,0). When these plasmids were transfected into BHK-21 cells
previously infected with a recombinant vaccinia virus that expressed T7 RNA
polymerase, we observed a low level of replication of PaV RNA1 and RNA2.
However, for use in BSR-T7/5 cells which express T7 RNA polymerase consti-
tutively (7) and thus eliminate the need for vaccinia virus infection, it proved
necessary to optimize the PaV RNA1 clone by adding a single guanylate residue
at the transcription initiation site (see Results and Discussion). The additional
nucleotide was introduced into plasmid PaV1(0,0) using Quik Change as de-
scribed by the supplier (Stratagene). A small DNA fragment spanning the mu-
tation was substituted into PaV1(0,0) to give PaV1(1,0), and the nucleotide
sequence of the substituted fragment was verified.
Screening for cells susceptible to infection with PaV. To screen cells for
susceptibility to infection with PaV, insect cell lines were plated in 35-mm-
diameter wells of six-well plates at an appropriate cell density to achieve 50 to
90% confluence. Cells were allowed to attach for at least 1 h at 28°C, washed
once with serum-free medium, and overlayed with 1 ml of serum-free medium
containing 5  1010 PaV or FHV particles. After 2 h of adsorption, 1 ml of
serum-containing medium was added and incubation was continued at 28°C.
RNA replication was assayed 24 h postinfection by metabolic labeling as de-
scribed below.
Transfection of BSR-T7/5 cells. For transfection with virion RNA (vRNA) or
with plasmids, BSR-T7/5 cells were plated in 35-mm-diameter wells of six-well
tissue culture plates and grown overnight at 37°C to reach 80 to 90% confluency.
The cells were washed twice with Dulbecco’s minimal essential medium
(DMEM) (catalogue number 12100-103; Gibco/BRL) and then overlayed with 1
ml of DMEM containing 20 l of Lipofectamine 2000 (Gibco/BRL) and 0.1 to
0.5 g of PaV vRNA or 2.5 g of PaV1(1,0) with or without 2.5 g of PaV2(0,0).
After incubation for 24 h at 28°C, the transfection mix was removed and replaced
by MEM containing serum. Incubation was continued at 28°C until 48 h post-
transfection, at which time the cells were either harvested or radiolabeled as
described below.
RNA and protein labeling, extraction, and analysis. The products of RNA
replication were radiolabeled by metabolic incorporation of [3H]uridine for 2 or
4 h in the presence of actinomycin D as previously described (2). For BSR-T7/5
cells actinomycin D was used at a working concentration of 5 g/ml, whereas for
insect cell lines it was necessary to increase the concentration of actinomycin D
to 20 g/ml to satisfactorily inhibit DNA-dependent RNA synthesis. Total RNA
was extracted from cells or virions using an RNAgents kit (Promega) as sug-
gested by the manufacturer. RNAs were resolved by electrophoresis on 1%
agarose-formaldehyde gels and visualized by fluorography (32).
The products of protein synthesis were metabolically labeled by incorporation
of either [35S]methionine-cysteine or [3H]leucine for 1 h in DMEM lacking
either methionine and cysteine or leucine, respectively. Total cell proteins were
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) using standard techniques (31). For fluorography, SDS-PAGE gels were
treated with 1 M sodium salicylate for 10 min before drying and exposure to
X-ray film.
Western blot analysis. Proteins were transferred from SDS-polyacrylamide
gels to polyvinylidene difluoride membranes in Towbin buffer (10 mM Tris base,
96 mM glycine in 10% methanol) by using a semidry graphite electroblotter
(Millipore) for 2 h at a constant current of 80 mA. PaV antiserum raised in
rabbits against the original isolate of PaV (45) was a gift from Jean-Louis
Zeddam. PaV antiserum was diluted 3,000-fold for use as the primary antibody
in the Immun-Star chemiluminescent protein detection system (Bio-Rad) ac-
cording to the manufacturer’s instructions.
Virus neutralization. For neutralization assays, PaV antiserum was diluted
20-fold in phosphate-buffered saline before addition of 1 l to each 20 l of virus
or BSR-T7/5 lysate sample. The samples were then incubated at room temper-
ature for 30 min.
Propagation and purification of clonally derived PaV. Larvae of the greater
wax moth (G. mellonella) were reared at 31°C as previously described (27).
Late-instar larvae (average weight, 150 mg) were injected with lysates derived
from either mock-transfected BSR-T7/5 cells (12 larvae) or cells transfected with
plasmids PaV1(1,0)  PaV2(0,0) (58 larvae). Larvae were incubated at 31°C for
8 days before being frozen at 	20°C. Larval homogenates were clarified by
low-speed centrifugation, and the virus was pelleted through a 30% sucrose
cushion. The redissolved virus pellet was injected into 92 larvae (average weight,
220 mg), with 12 larvae left uninfected. The larvae were collected after 8 days of
incubation and frozen at 	20°C until virus purification. Clonally derived PaV
was purified from frozen infected larvae as previously described (27) except that
50 mM Tris (pH 7.4) buffer was used throughout purification. Virus was resus-
pended in 50 mM Tris (pH 7.4) buffer and stored in aliquots at 	80°C. Virus
concentration was determined using an extinction coefficient at 260 nm of
4.15/mg and a particle mass of 9.2  106 g/mol, which was calculated on the basis
of the protein and RNA content of a PaV particle (27, 43).
RESULTS AND DISCUSSION
Cell lines susceptible to infection with PaV. Nine insect cell
lines were assayed for susceptibility to infection with PaV (Ta-
ble 1). We determined infectivity based on replication of PaV
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RNA in cells following exposure to 5  1010 PaV particles,
which corresponds to a multiplicity of infection (MOI) of
about 104 particles per cell. RNA replication was assayed by
metabolic labeling of RNAs with [3H]uridine in the presence
of actinomycin D, followed by separation of RNAs on dena-
turing agarose-formaldehyde gels and detection of the RNAs
by fluorography. Input RNA was not detected by this method
because only the products of RNA replication are actinomycin
D resistant and became labeled. PaV infection led to detection
of RNA replication in five of the cell lines: those from A.
albopictus (mosquito; ATC-15), S. exigua (beet armyworm;
Se-1) and H. zea (corn earworm; FB33, FB27 and MG8). The
level of RNA labeled varied among these cell lines but was
highest in FB33 cells. However, even in FB33 cells the level of
RNA labeled was at least 100-fold less than during FHV in-
fection of Drosophila DL-1 or DL-2 cells. FHV infection of
FB33 cells led to a similarly low level of RNA labeling. Under
the conditions used for the infectivity assay, there was no
evidence of PaV infection in the mosquito cell line Ae-59, a fall
armyworm line (Sf9), or the two Drosophila cell lines (DL-1
and DL-2) that are permissive for other alphanodaviruses such
as FHV, Black beetle virus (BBV), and Boolarra virus (12, 15,
35). The lack of detection of RNA replication in Sf9 cells
following exposure to PaV is consistent with the previous find-
ing by Zeddam et al. (45) that S. frugiperda larvae were not
susceptible to infection by PaV. Based on the results of the
infectivity assay, the H. zea fat body cell line FB33 was chosen
for use in further experiments with PaV.
The results of the infectivity assays suggested that PaV and
FHV may have cell specificities that only partially overlap. Of
the nine cell lines tested, only FB33 cells were susceptible to
both viruses. This is understandable in view of the different
isolation sites of the two viruses, their highly diverged genome
sequences (26, 27), and the distinct virion surface structures in
the putative receptor-binding region (43).
Titration of infectivity of PaV in FB33 cells. The initial
infectivity assays used arbitrary cell densities and a high MOI.
To optimize the infectivity assay for FB33 cells, we examined
the effect of cell density on RNA replication. Cells were plated
at a range of densities (5  105 to 4  106 cells per 35-mm-
diameter well), and replicating RNAs were labeled 24 h postin-
fection. The optimal cell density for infection with PaV was
found to be 2  106 cells in a 35-mm-diameter well, equivalent
to 70 to 80% confluency (data not shown). Using this optimum
cell density, we tested the effects of various MOIs ranging from
4  104 to 4  10	2 PaV particles per cell (Fig. 1). RNA1 and
RNA2 were clearly labeled at MOIs down to 4  102, and a
weak signal was detected at 4 101 particles per cell. No signal
was detected at lower MOIs. Thus, PaV infection of FB33 cells
could be readily detected at or above a MOI of 400 particles
per cell, a level similar to the previously reported optimal
MOIs for synchronous infection of DL-1 cells with BBV (17)
and consistent with the high particle-to-PFU ratio for FHV
(38, 41). In addition to the intense signals seen for the PaV
genomic RNAs, some weaker bands that were also present in
the mock-infected cells were visible. We attribute these to
residual labeling of rRNAs (Fig. 1).
Despite the evidence of PaV RNA replication, infected
FB33 cells showed no cytopathic effects even 5 days after
infection at an MOI of 104 particles per cell, and only low
levels of PaV capsid proteins were detected in cell lysates (data
not shown). In view of these results, it was not surprising that
attempts to develop a plaque assay for PaV in FB33 cells, as
was achieved for FHV and BBV in DL-2 cells (41), were
unsuccessful. Nevertheless, PaV infection could be passed re-
peatedly on FB33 cells, although infectivity increased by only 3
to 4 logs in a single passage. This contrasts with the infection of
DL-2 cells with FHV, which is highly productive (40). Despite
the low yields, FB33 cells provided a simple infectivity assay for
wild-type PaV and recombinant viruses recovered from cDNA
clones.
TABLE 1. Susceptibility of cell lines to infection
with Pariacoto virusa
Cell line Insect PaV FHV
Ae-59 Aedes aegypti (mosquito) 	b 
ATC-15 Aedes albopictus (mosquito)  	
DL-1 Drosophila melanogaster (vinegar fly) 	 
DL-2 Drosophila melanogaster 	 
FB27 Helicoverpa zea (corn earworm)  	
FB33 Helicoverpa zea  
MG8 Helicoverpa zea  	
Se-1 Spodoptera exigua (beet armyworm)  	
Sf9 Spodoptera frugiperda (fall armyworm) 	 	
a Susceptibility of cell lines to infection by either PaV or FHV as defined by the
infectivity assay described in Materials and Methods; , infectivity was detected;
	, no infectivity was detected.
FIG. 1. Infectivity of PaV in FB33 cells. Helicoverpa zea FB33 cells
were infected with 10-fold dilutions of purified PaV (MOIs of 4  104
to 4  100) or mock infected and incubated at 28°C. After 22 h of
incubation, actinomycin D was added at 20 g/ml, and 30 min later
replicating RNAs were metabolically labeled by incorporation of
[3H]uridine (20 Ci/ml) for a period of 2 h before total cellular RNAs
were harvested. RNAs were resolved by electrophoresis on a 1%
agarose-formaldehyde gel and visualized by fluorography. PaV
genomic RNA1 and RNA2 are identified on the left. The faint bands
below RNA2 are cellular RNAs that are present in all samples includ-
ing that from mock-infected cells.
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PaV RNA and protein synthesis in BSR-T7/5 cells. We
showed previously that PaV RNA replication can be initiated
in BHK-21 cells from the full-length cDNA clones PaV1(0,0)
and PaV2(0,0) (27). These plasmids were constructed such that
the major RNA transcripts made by T7 RNA polymerase ini-
tiated on the first nucleotide of the PaV RNA (adenosine) and,
after cleavage by the HDV ribozyme, had terminal nucleotides
that corresponded exactly to those of the PaV genomic RNAs.
In these original experiments, T7 RNA polymerase was pro-
vided by infection of BHK-21 cells with a recombinant vaccinia
virus (27). However, since the presence of vaccinia virus would
complicate experiments designed to produce infectious PaV,
for the present study we used the BHK-derived cell line BSR-
T7/5, which stably expresses T7 RNA polymerase under the
control of a cytomegalovirus pol II promoter (7). The replica-
tion of FHV RNAs transcribed from cDNA clones in these
cells has been characterized in detail (1).
BSR-T7/5 cells were transfected with vRNA, or with plasmid
PaV1(0,0) with or without PaV2(0,0), and 48 h posttransfec-
tion RNA replication products were labeled with [3H]uridine.
Despite strong replication of PaV vRNA, no RNAs were la-
beled in the cells transfected with PaV1(0,0) with or without
PaV2(0,0) (data not shown). Therefore, while previous exper-
iments had shown that PaV cDNA transcripts could initiate
RNA replication, and BSR-T7/5 cells could support authentic
vRNA replication (Fig. 2, lane 4), the original PaV transcrip-
tion plasmids failed to initiate RNA replication in BSR-T7/5
cells.
To overcome this problem, we inserted either one or two
additional G residues at the transcription initiation site in the
PaV1 plasmid to improve the sequence context of the T7
promoter and thereby enhance the level of DNA-templated
primary transcription (33). An additional G residue at the
initiation site for T7 transcription was also found necessary for
replication initiated by plasmids containing FHV1 cDNA (3).
BSR-T7/5 cells were transfected with PaV vRNA, PaV1(1,0),
or PaV1(2,0) alone or in combination with PaV2(0,0), and 48
h posttransfection RNA was metabolically labeled with [3H]-
uridine as before. Total cellular RNA was extracted and re-
solved on denaturing agarose-formaldehyde gels, and replica-
tion products were visualized by fluorography (Fig. 2). In cells
transfected with PaV1(1,0) (Fig. 2, lane 1) or PaV1(2,0) alone
(Fig. 2, lane 5), RNA replication was detected by the presence
of labeled RNAs corresponding to authentic PaV RNA1 and
RNA3 (Fig. 2, lane 4). Additionally, a small amount of an
RNA1 dimer (1, 27), seen most clearly in the vRNA sample
(Fig. 2, lane 4), was noted in cells transfected with plasmids for
RNA1. In cells transfected with PaV1(1,0)  PaV2(0,0) (Fig.
2, lane 2) or PaV1(2,0)  PaV2(0,0) (Fig. 2, lane 6), the RNA
replication products comigrated with authentic RNA1 and
RNA2. These results indicate that PaV RNA replication can
be initiated in BSR-T7/5 cells from the cDNA transcription
plasmids PaV1(1,0) or PaV1(2,0) in conjunction with PaV2(0,0).
PaV replication initiated from these plasmids establishes an
authentic pattern of RNA products, including the RNA2-me-
diated suppression of RNA3 synthesis (19, 46). Plasmid
PaV1(1,0) was chosen for further experiments.
At least one additional G nucleotide following the resected
T7 promoter was required to initiate PaV RNA replication in
cells that expressed T7 RNA polymerase constitutively, but not
in those that expressed the enzyme from a recombinant vac-
cinia virus (27). In the latter system, T7 transcripts are capped
and methylated in the cytoplasm by the vaccinia virus guanylyl-
and methyltransferases (18), which will enhance their transla-
tion efficiency. In contrast, primary transcripts made in the
cytoplasm of BSR-T7/5 cells are presumably not capped and
thus poorly translated. Consistent with this interpretation, in-
fection of BSR-T7/5 cells with wild-type, nonrecombinant vac-
cinia virus rescued the replication of RNA1 from PaV1(0,0),
confirming that vaccinia virus contributed to the recovery of
RNA replication from transcripts of this plasmid (data not
shown). We speculate that adding a G residue to the T7 pro-
moter increased the level of primary transcripts made from
PaV1(1,0), thus compensating for their lack of cap structures.
Unlike RNA1, which encodes the RNA-dependent RNA poly-
merase, RNA2 need provide no translation product before it
can replicate, and the transcripts made from PaV2(0,0) evi-
dently sufficed to initiate RNA2 replication. In both expression
systems, once RNA replication was established presumably all
products would be capped and methylated by PaV-specific
enzymes.
To examine PaV protein synthesis, BSR-T7/5 cells were
transfected with authentic vRNA or with plasmids PaV1(1,0) 
PaV2(0,0) and proteins were labeled with [35S]methionine-
cysteine or [3H]leucine 48 h posttransfection. Cytoplasmic ex-
FIG. 2. Replication of RNAs in BSR-T7/5 cells transfected with
PaV cDNA clones. BSR-T7/5 cells were mock transfected (lane 3),
transfected with 100 ng of vRNA (lane 4), or transfected with 2.5 g of
the following plasmids: PaV1(1,0) (lane 1); PaV1(1,0)  PaV2(0,0)
(lane 2); PaV1(2,0) (lane 5); or PaV1(2,0)  PaV2(0,0) (lane 6).
Following transfection, cells were incubated at 28°C for 48 h, at which
time 5 g of actinomycin D per ml was added, and incubation was
continued for 30 min before the RNAs were metabolically labeled by
incorporation of [3H]uridine (20 Ci/ml) for 4 h. Total cellular RNAs
were harvested, resolved by electrophoresis on a 1% agarose-formal-
dehyde gel, and visualized by fluorography. PaV RNA1, RNA2, and
RNA3 are identified on the left.
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tracts were resolved by SDS-PAGE, and labeled proteins were
visualized by fluorography (Fig. 3A). A protein of the size
expected for protein  was labeled both in cells transfected
with PaV vRNA and in cells transfected with PaV1(1,0) 
PaV2(0,0) plasmids (Fig. 3A, lanes 2, 4, 6, and 8), but not in
mock-transfected cells (Fig. 3A, lanes 3 and 7) or in cells that
received PaV1(1,0) alone (Fig. 3A, lanes 1 and 5). As expected
given the short period of labeling, little or no cleavage of
protein  into the mature capsid proteins  and  was ob-
served. Extensive shutoff of host protein synthesis was seen in
cells transfected with vRNA. In cells transfected with
PaV1(1,0) alone or together with PaV2(0,0), [3H]leucine la-
beling revealed an additional protein with an apparent Mr of
about 14 kDa (Fig. 3A, lanes 5 and 6) that was not present in
the untransfected cell sample (Fig. 3A, lane 7). The identifi-
cation of this as the B2 protein is described below.
To confirm the identity of the major labeled protein, the
samples were examined by Western blot analysis using a poly-
clonal rabbit antiserum raised against authentic PaV. Cytoplas-
mic extracts were resolved on SDS–12.5% polyacrylamide gels,
transferred to membranes, and probed with antiserum against
purified PaV (Fig. 3B). In purified virus particles the major
protein was the mature capsid protein , although small
amounts of the capsid precursor protein  and some putative
breakdown products were also present (Fig. 3B, lane 1). BSR-
T7/5 cells transfected with PaV vRNA contained proteins that
comigrated with both  and  (Fig. 3B, lane 5), suggesting
synthesis and some cleavage of the capsid precursor protein.
In comparison, cells transfected with the cDNA plasmids
PaV1(1,0)  PaV2(0,0) (Fig. 3B, lane 3) contained less capsid
protein precursor  and no detectable mature capsid protein .
The smaller amount of capsid proteins in this sample was
consistent with both the analysis of labeled proteins (Fig. 3A)
and the lower level of RNA replication compared to vRNA-
transfected cells (Fig. 2).
In addition to the capsid proteins, two minor bands were
detected in BSR-T7/5 cell extracts by Western blot analysis.
One of these was present in all samples, including the mock-
infected control, and therefore must represent a cellular pro-
tein. The other immunoreactive protein was present in all the
lysates except the mock-transfected control (Fig. 3B, lanes 2, 3,
and 5) and was similar in size to the 14-kDa protein detected
by [3H]leucine labeling (Fig. 3A). This protein was RNA1
related and corresponded in size to either of the two overlap-
ping open reading frames (ORFs) in PaV RNA3 (26) that are
analogous to the ORFs that encode the B1 and B2 proteins in
FHV RNA3 (16, 22, 23). Additionally, the 14-kDa protein was
more abundant in the absence of PaV2(0,0), suggesting that it
was translated from RNA3, which is inhibited by RNA2 (Fig.
2). To determine whether the 14-kDa protein was the product
of one of these ORFs, point mutations were introduced into
PaV1(1,0) to disrupt the initiation codons of either the B1 or
the B2 ORF. The first AUG of the B1 ORF was mutated to
GUG, which changed the initiating methionine of B1 to a
valine without altering the amino acid sequence of the B2
ORF. Because B1 is in the same reading frame as protein A,
the latter was also mutated at this position (M880V). The first
AUG of the B2 ORF was mutated to ACG, which changed the
B2-initiating methionine to threonine without altering the pro-
tein A or B1 amino acid sequences. The proteins synthesized in
FIG. 3. Viral proteins synthesized in BSR-T7/5 cells transfected
with PaV cDNA clones. (A) In vivo labeling. Cells were mock trans-
fected (lanes 3 and 7) or transfected with 100 ng of vRNA (lanes 4 and
8), or 2.5 g of PaV1(1,0) (lanes 1 and 5), or 2.5 g each of
PaV1(1,0)  PaV2(0,0) (lanes 2 and 6). After 48 h of incubation at
28°C, cells were preincubated for 30 min with medium lacking either
methionine and cysteine (lanes 1 to 4) or leucine (lanes 5 to 8), and
then proteins were metabolically labeled for 1 h with [35S]methionine-
cysteine (lanes 1 to 4) or [3H]leucine (lanes 5 to 8). Cytoplasmic
extracts were harvested, resolved by SDS-PAGE on 12.5% gels, and
visualized by fluorography. Proteins  and B2 are indicated on the left,
and the migration positions of molecular mass markers are shown on
the right. (B) Western blot analysis. Samples 5 to 8 from panel A were
also resolved by SDS-PAGE on a 12.5% mini-gel (lanes 2 to 5) along
with 250 ng of purified wild-type PaV virus particles (lane 1). Proteins
were transferred to a polyvinylidene difluoride membrane, probed with
a rabbit antiserum raised against purified PaV particles, and visualized
by chemiluminescence.
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BSR-T7/5 cells transfected with the mutant plasmids were an-
alyzed by [3H]leucine labeling and Western blot analysis, and
the results identified the 14-kDa protein as a product of the B2
ORF (data not shown).
Reactivity of the PaV antiserum with the B2 protein was
unexpected, as B2 is a nonstructural protein that is not nor-
mally present in purified virus preparations (Fig. 3B, lane 1).
We prepared a second antiserum by inoculation of a rabbit
with gradient-purified, clonally derived PaV (see Fig. 5, lane
5). This antiserum also detected B2 protein in the extracts of
vRNA-transfected BSR-T7/5 cells shown in Fig. 3B. Since both
antisera were polyclonal, we cannot exclude the possibility that
both of the purified virus samples used as antigens contained
undetectable levels of B2 protein. However, it seems more
likely that some virus replication and concomitant B2 protein
synthesis occurred in each of the rabbits in which the antisera
were raised. The host-range of PaV has not been examined,
and another alphanodavirus, Nodamura virus, is able to repli-
cate in some mammals (5); thus, it is possible that PaV repli-
cated in the immunized rabbit. In these experiments we found
no evidence for expression of the B1 ORF, which in PaV
RNA3, unlike the situation in FHV, begins downstream of the
B2 ORF. However, the predicted amino acid sequence of the
B1 ORF contains only one methionine, no cysteines, and one
leucine, so it is possible that synthesis of B1 protein would not
have been detected by using the methods described here.
Recovery of infectious virus from BSR-T7/5 cells. To test
whether the cDNA clones yielded infectious virus, lysates were
prepared from BSR-T7/5 cells that had been transfected with
PaV1(1,0)  PaV2(0,0). An aliquot of the lysate and a control
sample containing 109 purified PaV particles were treated with
anti-PaV antiserum, with RNase A, or both. FB33 cells were
infected with the treated and mock-treated samples, and 24 h
postinfection RNAs were metabolically labeled with [3H]uri-
dine, resolved on denaturing agarose gels, and visualized by
fluorography (Fig. 4). RNA replication was evident in cells
infected with untreated PaV particles and with the untreated
lysate from BSR-T7/5 cells that had been transfected with
PaV1(1,0)  PaV2(0,0) (Fig. 4, lanes 1 and 5). RNase A
treatment did not affect this infectivity (Fig. 4, lanes 2 and 6).
In contrast, treatment with anti-PaV antiserum decreased the
infectivity of both authentic and cDNA-derived PaV to below
the limits of detection (Fig. 4, lanes 3 and 7). These results
demonstrate that infectious PaV was generated in BSR-T7/5
cells following transfection with plasmids that contained cDNA
copies of PaV RNA1 and RNA2.
Growth of PaV in G. mellonella larvae. In order to prepare a
large stock of clonally derived virus, a lysate of BSR-T7/5 cells
transfected with PaV1(1,0)  PaV2(0,0) was injected into G.
mellonella larvae. Following 8 days of incubation at 31°C, the
nonpupated larvae (approximately 70%) were collected and
frozen at 	20°C. Cadavers were homogenized in 50 mM Tris
(pH 7.4), and the clarified homogenates were pelleted through
a 30% sucrose cushion and resuspended in 50 mM Tris (pH
7.4). The resuspended pellets were subjected to SDS-PAGE,
and the proteins were stained with Coomassie brilliant blue
(Fig. 5). Two major proteins were visible in extracts from
infected larvae (Fig. 5, lane 4) that were not present in unin-
fected samples (Fig. 5, lane 3). One of these bands comigrated
with the major capsid protein from purified wild-type PaV
(Fig. 5, lane 2), and the other was about 4 kDa larger, which is
the size expected for the PaV capsid protein precursor . As
described previously (27), the small capsid protein  was not
visualized by Coomassie blue staining. These results indicated
that BSR-T7/5 cells transfected with PaV1(1,0)  PaV2(0,0)
generated PaV particles that were infectious for G. mellonella
larvae.
To amplify the clonally derived virus, the larval extracts
described above were repassaged in G. mellonella larvae, and
after 8 days of incubation at 31°C the virus was purified as
described in Materials and Methods. Seven milligrams of re-
combinant virus was purified from 92 G. mellonella larvae. The
purified clonally derived virus was examined by SDS-PAGE
and found to contain a single major protein that comigrated
with the major capsid protein of authentic wild-type PaV (Fig.
5, lanes 5 and 6). Furthermore, at equivalent MOIs (similar to
those shown in Fig. 1), the recombinant and wild-type viruses
produced similar patterns of labeled RNAs in infected FB33
cells (data not shown).
In summary, we have described a cell-based infectivity assay
for PaV and used it to recover infectious virus from cDNA
clones. Although infected FB33 cells produced only modest
amounts of virus, amplification of the clonally derived virus in
G. mellonella larvae provided quantities of virus which have
FIG. 4. Neutralization of authentic and clonally derived PaV. BSR-
T7/5 cells were transfected with 2.5 g of PaV1(1,0)  PaV2(0,0) and
incubated at 28°C for 48 h before the cells were washed and lysed by
freezing and thawing. These lysates (lanes 5 to 8) and purified wild-
type PaV particles (lanes 1 to 4) were incubated with RNase A (lanes
2 and 6), PaV antiserum (lanes 3 and 7), or both RNase A and PaV
antiserum (lanes 4 and 8), or mock-treated with PBSM (lanes 1 and 5).
The treated samples were used to infect FB33 cells. After 22 h of
incubation at 28°C, actinomycin D was added at 20 g/ml, and 30 min
later replicating RNAs were metabolically labeled by incorporation of
[3H]uridine (20 Ci/ml) for a period of 2 h before total cellular RNAs
were harvested. RNAs were resolved by electrophoresis on a 1%
agarose-formaldehyde gel and visualized by fluorography. PaV RNA1
and RNA2 are indicated on the left.
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previously been sufficient for structural examination. Previous
studies of nodavirus assembly have focused on FHV partly
because of the availability of susceptible cell lines and infec-
tious cDNA clones (25, 37). The work described above makes
PaV only the second nodavirus for which these experimental
tools are available and provides methods to investigate the
mechanisms of RNA encapsidation and virion assembly. These
studies will be guided by the high-resolution structure of PaV,
which revealed many contacts between the capsid proteins and
the genomic RNAs of this virus.
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